Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $39.77B | 1.90% | 1.10% | 3.08% | 6.60% | 0.85 | 2.39 | 86.20% | 1.40% | 3.26% | ||
| NVO | NOVO NORDISK A S | $219.81B | 61.10% | 20.20% | 39.89% | 51.50% | 1.80 | 0.80 | 81.00% | 33.10% | 42.24% | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.44B | 7.50% | 5.60% | 8.26% | 14.10% | 0.33 | 3.85 | 87.50% | 6.00% | 8.13% | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $486.97M | 42.70% | 16.10% | 25.35% | 37.20% | 1.03 | 8.62 | 80.70% | 41.90% | 73.31% | ||
| CORT | CORCEPT THERAPEUTICS INC | $4.19B | 15.90% | 12.60% | 9.84% | 11.20% | 0.30 | 3.14 | 98.20% | 14.10% | 8.65% | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $44.12B | 90.30% | 6.70% | 16.45% | 11.30% | 5.29 | 2.76 | 81.60% | 8.40% | 15.50% | ||
| VCEL | VERICEL CORP | $1.89B | 4.30% | 3.00% | 3.40% | 3.50% | 0.41 | 4.87 | 73.80% | 5.10% | 5.35% | ||
| ARGX | ARGENX SE | $51.60B | 24.70% | 21.40% | 10.88% | 20.20% | 0.18 | 5.60 | -19,733.10% | 78,552.00% | 40,946.87% | ||
| GMAB | GENMAB A | $18.73B | 17.40% | 11.70% | 12.87% | 45.20% | 1.20 | 2.02 | 93.60% | 25.90% | 39.60% | ||
| KRYS | KRYSTAL BIOTECH INC | $8.28B | 18.70% | 17.10% | 15.39% | 26.00% | 0.09 | 9.95 | 94.10% | 52.60% | 48.69% | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.74B | 5.70% | 4.50% | 4.62% | 9.50% | 0.55 | 24.69 | 94.30% | 19.30% | 26.59% | ||
| TECH | BIO-TECHNE CORP | $9.28B | 4.10% | 3.20% | 5.15% | 9.40% | 0.25 | 4.54 | 65.20% | 6.70% | 10.09% | ||
| ADMA | ADMA BIOLOGICS INC | $3.81B | 54.00% | 39.40% | 32.05% | 35.70% | 0.32 | 7.13 | 54.70% | 42.90% | 33.60% | ||
| MNKD | MANNKIND CORP | $1.67B | -49.30% | 6.80% | 16.19% | 11.30% | -12.10 | 3.29 | 75.20% | 9.30% | 19.89% | ||
| ABEO | ABEONA THERAPEUTICS INC | $277.46M | 78.40% | 48.00% | 41.45% | 86.10% | 0.35 | 9.74 | -22.00% | 20,587.50% | 21,650.75% | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.64B | 92.70% | 14.10% | 20.65% | 20.10% | 50.73 | 4.66 | 83.60% | 22.70% | 34.73% | ||
| RPRX | ROYALTY PHARMA PLC | $26.15B | 8.00% | 4.10% | 5.68% | 4.40% | 1.02 | 2.40 | 100.00% | 32.40% | 45.35% | ||
| VCYT | VERACYTE INC | $2.89B | 2.50% | 2.30% | 2.39% | 15.10% | 0.09 | 6.23 | 68.50% | 6.10% | 6.26% | ||
| XOMA | XOMA ROYALTY CORP | $301.53M | 20.30% | 7.20% | 10.39% | 12.10% | 1.77 | 3.91 | 100.00% | 35.20% | 51.78% | ||
| NAGE | NIAGEN BIOSCIENCE INC | $399.03M | 34.60% | 24.10% | 28.18% | 203.70% | 0.39 | 4.12 | 63.90% | 16.40% | 17.04% | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $239.66M | 11.30% | 7.00% | 12.37% | 18.00% | 0.56 | 3.03 | 57.50% | 8.70% | 12.06% | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.03B | 24.90% | 17.00% | 24.96% | 55.80% | 0.45 | 3.76 | 77.70% | 22.50% | 29.76% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.99B | 26.40% | 23.00% | 30.97% | 370.30% | 0.14 | 6.62 | 85.70% | 37.60% | 49.43% | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.89B | 21.80% | 14.90% | 18.63% | 18.80% | 0.44 | 5.76 | 88.90% | 29.30% | 31.63% | ||
| APLS | APELLIS PHARMACEUTICALS INC | $2.81B | 18.90% | 5.00% | 11.77% | 12.30% | 1.64 | 3.54 | 88.80% | 4.40% | 9.02% | ||
| CRMD | CORMEDIX INC | $564.92M | 81.80% | 51.10% | 17.50% | 93.70% | 1.01 | 1.94 | 92.60% | 75.80% | 50.40% | ||
| REGN | REGENERON PHARMACEUTICALS INC | $83.75B | 14.80% | 11.50% | 14.57% | 15.60% | 0.30 | 4.13 | 85.40% | 31.40% | 36.77% | ||
| UTHR | UNITED THERAPEUTICS CORP | $20.50B | 18.80% | 16.80% | 24.85% | 31.70% | 0.12 | 6.40 | 88.60% | 40.70% | 54.04% | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.88B | 8.80% | 7.10% | 10.12% | 12.20% | 0.26 | 4.83 | 81.30% | 16.80% | 22.30% | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $3.93B | 32.30% | 21.40% | 28.09% | 51.70% | 0.45 | 3.02 | 91.90% | 24.90% | 26.14% | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $119.47B | 22.70% | 16.20% | 21.38% | 29.90% | 0.37 | 2.90 | 86.20% | 32.90% | 38.80% | ||
| INVA | INNOVIVA INC | $1.77B | 16.60% | 9.60% | 12.65% | 18.40% | 0.42 | 14.12 | 81.50% | 32.80% | 44.95% | ||
| EXEL | EXELIXIS INC | $11.55B | 36.90% | 28.00% | 38.59% | 42.20% | 0.32 | 3.56 | 96.40% | 33.70% | 40.57% | ||
| MDXG | MIMEDX GROUP INC | $773.09M | 19.20% | 14.30% | 20.39% | 49.90% | 0.34 | 4.41 | 82.00% | 10.40% | 13.54% | ||
| INCY | INCYTE CORP | $20.50B | 29.10% | 20.70% | 30.63% | 77.30% | 0.35 | 3.32 | 92.80% | 25.00% | 32.42% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.